Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN hepatology committee position statement

G Mieli-Vergani, D Vergani, U Baumann… - Journal of pediatric …, 2018 - journals.lww.com
Paediatric autoimmune liver disease is characterized by inflammatory liver histology,
circulating autoantibodies, and increased levels of IgG, in the absence of a known etiology …

The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration

MR Deneau, W El‐Matary, PL Valentino, R Abdou… - …, 2017 - Wiley Online Library
There are limited data on the natural history of primary sclerosing cholangitis (PSC) in
children. We aimed to describe the disease characteristics and long‐term outcomes of …

Autoimmune hepatitis, sclerosing cholangitis, and autoimmune sclerosing cholangitis or overlap syndrome

N Kerkar, A Chan - Clinics in liver disease, 2018 - liver.theclinics.com
Autoimmune liver disease in pediatrics encompasses autoimmune hepatitis (AIH),
autoimmune overlap with sclerosing cholangitis (SC), recurrence of AIH after liver …

[PDF][PDF] Lipid remodeling in hepatocyte proliferation and hepatocellular carcinoma

Z Hall, D Chiarugi, E Charidemou, J Leslie, E Scott… - …, 2021 - Wiley Online Library
Background and Aims Hepatocytes undergo profound metabolic rewiring when primed to
proliferate during compensatory regeneration and in hepatocellular carcinoma (HCC) …

[HTML][HTML] Treatment of primary sclerosing cholangitis in children

TJ Laborda, MK Jensen, M Kavan… - World journal of …, 2019 - ncbi.nlm.nih.gov
Primary sclerosing cholangitis (PSC) is a rare disease of stricturing and destruction of the
biliary tree with a complex genetic and environmental etiology. Most patients have co …

Defining primary sclerosing cholangitis: results from an international primary sclerosing cholangitis study group consensus process

CY Ponsioen, DN Assis, KM Boberg, CL Bowlus… - …, 2021 - gastrojournal.org
Although patients with PSC are increasingly diagnosed at earlier stages of disease based
on asymptomatic serum liver enzyme abnormalities, at least 45% of patients PSC present …

The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) index: a prognostic tool for children

MR Deneau, C Mack, ER Perito, A Ricciuto… - …, 2021 - Wiley Online Library
Background and Aims Disease progression in children with primary sclerosing cholangitis
(PSC) is variable. Prognostic and risk‐stratification tools exist for adult‐onset PSC, but not …

[PDF][PDF] Gamma glutamyltransferase reduction is associated with favorable outcomes in pediatric primary sclerosing cholangitis

MR Deneau, C Mack, R Abdou, M Amin… - Hepatology …, 2018 - Wiley Online Library
Adverse clinical events in primary sclerosing cholangitis (PSC) happen too slowly to capture
during clinical trials. Surrogate endpoints are needed, but no such validated endpoints exist …

The intestinal microbiome and paediatric liver disease

DH Leung, D Yimlamai - The Lancet Gastroenterology & Hepatology, 2017 - thelancet.com
The intestinal microbiome has been the intense focus of recent study, but how the microbiota
affects connected organs, such as the liver, has not been fully elucidated. The microbiome …

Clinical features and MRI progression of small duct primary sclerosing cholangitis (PSC)

KI Ringe, A Bergquist, H Lenzen, N Kartalis… - European Journal of …, 2020 - Elsevier
Purpose First, to evaluate and describe the clinical and MRI progression of patients with
small duct primary sclerosing cholangitis (sdPSC), and second, to look for MRI features …